• UCLA Health
  • myUCLAhealth
  • School of Medicine
UCLA Health

UCLA Health
  • About Us
    • What is UCLA Health?
    • Contact Us
    • Your Feedback
    • Accountable Care Organization
    • Awards & Achievements
    • Careers
    • Careers for Physicians
    • Departments - Administrative
    • Departments - Clinical
    • Giving to UCLA Health
    • Health Equity, Diversity & Inclusion
    • In the Community
    • Industry Relations
    • Innovation
    • Leadership
    • News Releases
    • Price Transparency
    • Social Media
    • #TeamLA
    • 340B Program
    Vital SignsLinked Graphic: Subscribe to Health Newsletters
    • Contact
    • Your Feedback
    • Accountable Care Organization
    • Awards and Achievements
    • Careers
    • Careers for Physicians
    • Departments - Administrative
    • Departments - Clinical
    • Giving to UCLA Health
    • Health Equity, Diversity and Inclusion
    • Innovation
    • In the Community
    • 340B Program
    • Leadership
    • News Releases
    • Price Transparency
    • Social Media
    • TeamLA
    • Subscribe to UCLA Health Newsletters
  • Conditions & Treatment
    • Health Library
    • Tests & Procedures
    • Drug Interaction Checker
    • Brain & Nervous System
    • Cancer
    • Children's Health
    • Heart Disease
    • Nutrition & Wellness
    • Pregnancy & Newborns
    • Orthopedics
    • Women's Health
    • Video Library
    • Cancer
    • Cardiovascular
    • Chiropractic
    • Cosmetic Surgery
    • Ear, Nose and Throat
    • Gastrointestinal
    • General Healthcare
    • Neurological
    • Obstetrics/Gynecology
    • See all videos...
    Symptom Checker
    • Video Library
  • Locations

    Hospitals

    • Ronald Reagan UCLA Medical Center
    • UCLA Santa Monica Medical Center
    • UCLA Mattel Children's Hospital
    • Resnick Neuropsychiatric Hospital
    • Institutes and Centers
    • Take a Virtual Tour

    Medical Offices/Clinics

    • Primary Care
    • Specialty Care
    • Immediate Care
    • Emergency Care
    • Outpatient Surgery Centers
    • Community Cancer Care
    • Pediatric Locations
    • Imaging/Radiology
    • Clinical Labs
    • Pharmacies

    Interactive Map

    interactive map

    • Interactive Map
    • UCLA Medical Plazas
    • Locations Coming Soon
    • UCLA Hospitals
    • Take a Virtual Tour
    • Primary Care Practices
    • Specialty Care Practices
    • Immediate Care
    • Emergency Care
    • Pediatric Locations
    • Outpatient Surgery Centers
    • Clinical Labs
    • Pharmacies
    • Other Locations
    • Interactive Map
    • Coming Soon!
  • Medical Services
  • For Patients & Visitors
    • Directions & Parking
    • Appointments
    • Video Visits
    • Medical Chaperones
    • Admissions
    • Preparing For Surgery
    • Patient Services
    • Security & Parking Services
    • Office of the Patient Experience
    • For International Patients
    • Lodging & Nearby Services
    • Around Westwood
    • Gift Shops & Flowers
    • Patient Greeting Cards
    • Coronavirus Resources
    • Log in to myUCLAhealth
    • Billing and Insurance
    • Medical Records
    • Price Transparency
    • Health Encyclopedia
    • Interactive Patient Education Videos (Emmi)
    • FAQs
    • Calendar of Events
    • Secure Email Messages
    • Health Resources
    • Multimedia
    • Download our Apps
    • Doctor on video visit
    • Open Enrollment
    • Visit our Connect Blog
    • Send a Care Compliment
    • Read Health Publications
    • Vital Signs Newsletters
    • Join a Patient and Family Advisory Council
    • Share your Feedback
    • Contact Us
    • Appointments: Call, Click, Come in
    • Video Visits - Telemedicine
    • Medical Chaperones
    • Admissions Information
    • Advance Directive
    • Directions & Parking
    • Patient Services
    • Medical Records
    • myUCLAhealth
    • Smoke-Free
    • Publications
    • Multimedia
    • Health Resources
    • Around Westwood
    • Lodging
    • Preparing For Surgery
    • Patient-focused Technology Council
    • Health Forms
    • End of Life Option Act: Resources & Materials
    • Frequently Asked Questions
    • Secure Email Messages
    • Gift Shops
    • Patient Greeting Cards
  • For Healthcare Professionals
    • Referring a Patient
    • Continuing Medical Education
    • Ethics Center
    • UCLA HealthLink
    • Physician to Physician Access Line (P2P)
    • David Geffen School of Medicine at UCLA
    • Clinical Informatics Fellowship
    • Academic Positions
    • Physician Careers
    • UCLA School of Dentistry
    • UCLA School of Nursing
    • Department of Nursing

    Physician Publications

    • Physicians Update
    • Clinical Updates
    • U Magazine
    • Physician to Physician Access Line (P2P)
    • Physician Careers
    • Clinical Informatics Fellowship
    • Flu Resources for Healthcare Professionals
    • Publications
  • Clinical Research
    • All Clinical Trials
    • COVID-19 Clinical Research
  • Find a Provider
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

News Releases

  1. Home
  2. About Us
  3. News Releases

News Releases

Health and Behavior

UCLA Biodesign Fellow Focuses Surgical, Medical and Biomedical Engineering Insights on a Weak Link in the COVID-19 Testing Process: Swabs Shortage

"Swabs are a relatively simple component. But testing can’t happen without them." --- Gabe Oland, MD, UCLA Biodesign Fellow

04/24/2020

Not all swabs are alike. Some have fibers woven around the tip, similar to cotton swabs found in stores, but made with longer shafts and sterile, spongy materials. But the quickest-to-produce swabs consist of a single plastic material from tip to tip.

LOS ANGELES (4/24/20) -- When the COVID-19 outbreak became a pandemic, and the scarcity of testing supplies became a crisis, the leaders of UCLA Biodesign saw the experience and background of Gabriel Oland, MD, as the ideal combination to help reinforce one link in the strained supply chain: the nasopharyngeal swabs used to collect patient specimens for testing.

With quick action and a collaborative effort, UCLA Health now has a protocol approved by the institutional review board (IRB) and launched this week a validation study of new swabs.

Oland, a general surgery resident at UCLA David Geffen School of Medicine and a fellow in the UCLA Biodesign program, has been working to develop a noninvasive intracranial pressure monitoring device. But with his medical and surgical experience – including treating COVID-19-positive patients – his undergraduate degree in biomedical engineering, his familiarity with production methods like 3D printing and injection molding, and his innovative work in the UCLA Biodesign program, he seemed to be the right person to bring together manufacturers and clinicians to rapidly address the issue of dwindling supplies of testing swabs.

Largely because of skills he honed during his UCLA Biodesign fellowship year, and in lieu of his externship, Oland was asked by Desert Horse-Grant to be her co-lead on the COVID-19 test swab task force.

"With Gabe's understanding of medicine, engineering and business, he has the expertise to think through COVID-19 obstacles and outsmart them with the right experts," said Horse-Grant, senior director of UCLA Health Research and Innovation and co-executive director of UCLA Biodesign.

"Compared with everything else that goes into testing, nasopharyngeal swabs are a relatively simple component," said Oland. "But testing can't happen without them."

In April, he researched manufacturing companies – many of which were not medical-grade manufacturers – working with them, and in some cases giving them design feedback, so they could develop and mass-produce swabs that are safe and may be effective for clinical use. Because the Food and Drug Administration, which normally requires lengthy and thorough testing and validation of new medical products, has been inundated hospitals and manufacturers have been mandated to take on the additional responsibility of validating these products themselves so that they can then provide supportive data to the FDA retroactively, Oland said.

"Many entities have completely pivoted in what they're doing. Some print consumer goods; others print jewelry and athletic wear. It's difficult for these companies to make the transition to making medical-grade equipment, yet most of them are also manufacturing more or less at cost, with no intention of trying to gain economically from their contributions," he said.

"The most fascinating is how quickly industry, healthcare systems and regulatory agencies alike have had to adapt and be flexible, given the time constraints that we’re under," said Oland, who will help lead clinical evaluations of new swabs this week.

Not all swabs are alike, and not all can be mass-produced on 3D printers. Some have fibers woven around the tip, similar in appearance to cotton swabs found in stores for consumer use, but made with longer shafts and sterile, spongy materials. But to meet the rapidly growing need for testing, the quickest-to-produce swabs consist of a single plastic material from tip to tip, with a lattice or a honey dipper design to collect a sample at one end.

"Given that it's only using one material, 3D printing is perfect for rapid output," Oland said.

Pathologist Omai Garner, PhD, who directs clinical microbiology testing for UCLA Health, said, "Testing is our way out of this crisis, and as a country, we haven't even scratched the surface of the amount of testing we need to be able to do."

Garner's team, which previously used about 200 swabs a day, now needs another 500 daily for COVID-19 testing alone and expects they'll need twice that number over the next few weeks as testing ramps up.

"The scale at which we need swabs is something that's never been seen before," Garner said, adding that every person who is symptomatic for COVID-19 needs to be tested quickly, with results provided within 24 hours.

"At UCLA, we're also exploring how we can test patients who may be asymptomatic and are coming into our hospitals for procedures, potentially exposing our workers to infection," Garner said. "UCLA Health is among the best in the country for many procedures, and we want to ensure continuity and future success by making appropriate COVID-19 testing available."

While hospitals and patients are desperate for testing supplies that will save lives, the new swab manufacturers need validating data from the medical community to eventually obtain FDA approval to continue their work.

"Once the FDA gives their approval to the best-performing swabs, health systems won't need to do as much clinical validation in-house. We'll be able to start using the tests right away, potentially up to a few thousand a day at UCLA alone. I anticipate that very soon, extremely high-throughput testing will be available nationwide. We are facing tough times, but we also have many reasons to be optimistic – the challenges we're dealing with pose a unique opportunity for growth, and everyone with whom I’ve been working has risen to the occasion," Oland said.

"UCLA Biodesign innovators like Gabe immediately turned their attention to resolving some of the most pressing problems brought on by the quick spread of COVID-19 and the dramatic spike in demand for testing and other supplies," said Johnese Spisso, president of UCLA Health, CEO of UCLA Health System, and a member of the UCLA Biodesign Program Advisory Board.



Media Contact
Sandy Van
808-526-1708
sandy@prpacific.com

 
See All News
 


Latest News

Health and Behavior
New AI approach enables research collaboration while protecting patient privacy
03/08/2021
Within the field of artificial intelligence (AI), deep learning is an area of rapid and high-impact innovation in the healthcare industry.

Health and Behavior
Mythbusting: You cannot get COVID-19 from the vaccines … and other truths
03/04/2021
UCLA Health share medically sound, evidence-based information about the safety and effectiveness of all of the vaccines.

Health and Behavior
UCLA Health receives $5 million for home visit program
03/04/2021
The gift, from longtime donors Maxine and Eugene Rosenfeld, supports care for older adults.

Health and Behavior
Study unravels antibiotic resistance in MRSA 'superbug' infections
03/03/2021
Research brief: An approach pioneered at UCLA predicts which methicillin-resistant Staphylococcus aureus infections are likely to be cured with antibiotic therapy.

Health and Behavior
Ownership's hidden rules: Q&A with 'Mine!' co-author James Salzman
03/02/2021
In the new book he co-wrote, Salzman reveals the hidden rules that govern who owns what — from the reclining space behind airline seats to HBO passwords.

Facebook Twitter Instagram Youtube LinkedInWeibo
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap

Sign in to myUCLAhealth

Learn more about myUCLAhealth